MMWR on Opioids
Opioid prescribing rates have declined across rural and metropolitan areas while evidence of fentanyl in drugs seized by law enforcement is variably up and down, depending on the region of the country. These insights are summarized in the January 18, 2019 issue of CDC's Morbidity and Mortality Weekly Report (MMWR). Findings of note, and their corresponding articles, include the following. (Note: HRSA's HIV/AIDS Bureau has a new funding announcement, Strengthening Systems of Care for People Living with HIV and Opioid Use Disorder.)
- "Significant decreases in opioid prescribing occurred across all urban-rural categories after the March 2016 release of the CDC Guideline for Prescribing Opioids for Chronic Pain." See Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System — United States, 2014–2017.
- "Ohio, Pennsylvania, and Massachusetts, the three states with the largest numbers of fentanyl submissions during January–June, 2017 (accounting for 48% of all fentanyl submissions) experienced an average 13% decline during July–December, 2017.... In contrast, the number of fentanyl submissions increased 8% in the South (from 5,883 to 6,341) and 36% in the West (from 547 to 743) during the same period." See Notes from the Field: Fentanyl Drug Submissions — United States, 2010–2017.
This issue of MMWR also contains an article on the dramatic increase in opioid deaths involving fentanyl in New York City, from 2000-2017. See Overdose Deaths Involving Fentanyl and Fentanyl Analogs — New York City, 2000–2017.
Learn more about Opioid Basics